Back to Research
AC
ACONW
Aclarion, Inc. Warrant
SERVICES-MEDICAL LABORATORIES
--
Price Chart
Market Cap
--
Volume
27.68K
52W High
$0.24
52W Low
$0.01
Open
$0.05
Prev Close
$0.07
Day Range
0.04 - 0.05
About Aclarion, Inc. Warrant
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
Latest News
Aclarion Provides 2025 Update and 2026 Corporate Outlook
GlobeNewswire Inc.•1/8/2026
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data
GlobeNewswire Inc.•1/6/2026
Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
GlobeNewswire Inc.•10/22/2025
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference
GlobeNewswire Inc.•10/13/2025
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
GlobeNewswire Inc.•10/7/2025
First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial
GlobeNewswire Inc.•9/25/2025
Aclarion Appoints Greg Gould as Chief Financial Officer
GlobeNewswire Inc.•9/3/2025
First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
GlobeNewswire Inc.•6/25/2025